Safal Softcom

Case Study: Health Care Industry

Accretion achieved Value-based Accomplishment (VBA) with SAFAL’s Digitalized e-sourcing.

Accretion Pharmaceuticals is India’s major maker and exporter of medicinal dosage forms in a variety of formulations. It is underpinned by WHO-established international quality standards and a cutting-edge production facility. Accretion Pharmaceuticals is accredited from International body such as WHO-cGMP, ISO 9001:2015, ISO 14001:2015 & ISO 22000:2005 certified company. Manufacturers must give greater value than ever before to survive and grow in the medical device market, as competition heats up.

University of Nairobi

The University of Nairobi recently conducted a research to evaluate e-procurement procedures and operational performance.

According to the study’s findings, 

E-planning allowed pharmaceutical manufacturing companies to flag pharmaceuticals that were needed at a specific time and place, as well as the distribution of the same drugs across multiple warehouses.

It also aids corporations in controlling the creation of items with strict expiration dates, and it provides buyers and suppliers with a way to acquire information on the performance of the pharmaceuticals they purchase from the firm.

E-planning, E-supplier selection, E-tendering, and E-sourcing all have an impact on the operational performance of pharmaceutical manufacturing enterprises in Nairobi, according to the regression study.

This study suggests that companies should invest more in e-procurement in order to get the most out of it, such as expanding their supplier base.

These sectors go through a variety of manual and machine-based processes, beginning with drug content research and progressing through the drug formulation development process and manufacture. Resulting in following challenges:

  • Because the market is spread across a large number of geographically dispersed locations across the world, it is critical that manufactured medications reach their destinations on time, as there is a risk of expiration in the case of allopathic medicines. This has a significant impact on the company's operations.



  • The needs and requirement of the market keeps on changing based on the current healthcare environment in the country. 
  • In order to Ensuring right drugs in required quantity is really important. Market restrictions change from one country to the next.
  • Difficult to address regulatory compliance issues and adjust quality requirements
  • Poor flow of information and inefficient process

Impact of COVID-19 on current Healthcare Industry

The COVID-19 epidemic has prompted enormous responses from national governments all over the world, as well as trade disruptions and a profound and widespread economic crisis on a worldwide scale. All of these causes are putting a strain on the availability of crucial medicines and other necessities. The pervasive occurrence of these issues reflects the fact that the pharmaceutical and healthcare commodities supply chain is both very complex and highly globalized.

Major Challenges:

Substantial reductions in air cargo capacity, sea freight capacity, and transportation logistics capacity have resulted in severe supply chain disruptions.

Export restrictions imposed by supply countries on both COVID-specific goods and non-COVID commodities

The reduction in the amount of medicine produced in the impacted countries. This started with the manufacture of APIs in China.

SAFAL e-sourcing Implementation:

Accretion implemented the innovative Procure-2-Pay solution with built in PO to Invoice exception management framework. Safal’s e-Sourcing addresses complex order fulfillment and payment challenges of large-scale Order-2-pay process.

It provides seamless integration with any world class ERP. Addresses purchase order reconciliation challenges with suppliers by the time order is fulfilled. Reduces manual interventions and streamlines P2P.

Digitally connects Purchase Order, PO acknowledgments, Advance Shipment Notice, GRN and Invoices. Here are the e-sourcing solution’s various features with its functionality:

Transformation after e-Sourcing Implementation:

  • Because the effectiveness of an e-procurement process in a pharmaceutical manufacturing firm is strongly associated with timely supplier selection, it is this factor that defines the overall performance of the organisation.
  • E-supplier selection enables manufacturing companies to create a pool of competent suppliers for real-time requests, to pick suppliers for a variety of products and services online without the need for human participation, and to use online data in the pricing of items.
  • Decreased production cost and improved operational performance. Allows paperless selling. 
  • Enhanced flow of information throughout the process.

Transformation after e-Sourcing Implementation:

  • Because the effectiveness of an e-procurement process in a pharmaceutical manufacturing firm is strongly associated with timely supplier selection, it is this factor that defines the overall performance of the organisation.
  • E-supplier selection enables manufacturing companies to create a pool of competent suppliers for real-time requests, to pick suppliers for a variety of products and services online without the need for human participation, and to use online data in the pricing of items.
  • Decreased production cost and improved operational performance. Allows paperless selling. 
  • Enhanced flow of information throughout the process.

Thus it is proved that electronic procurement helped pharmaceutical manufacturing companies improve their operational performance through

Thus it is proved that electronic procurement helped pharmaceutical manufacturing companies improve their operational performance through

Cost Reduction a big time

Decreased delivery costs

Improved order processing

Reduced material lead times

Decreased delivery costs

Improved product/service quality

Increased order placement.